Navigation Links
OrbusNeich Announces Availability of Azule™ Cobalt Chromium Stent
Date:3/14/2011

HONG KONG, March 14, 2011 /PRNewswire/ -- OrbusNeich today announced the launch of the CE marked Azule Cobalt Chromium Stent.  The Azule Stent combines the proven stent design of its predecessor, the company's Blazer™ Cobalt Chromium Stent, with a delivery system with enhanced crossability and flexible deliverability.

Azule features OrbusNeich's unique Dual Helix stent design, offering conformability and radial strength on thin, flexible and low-profile cobalt chromium stent struts.  The stent's tip length has been reduced from 5 mm to 4.25 mm, improving deliverability and crossability.  The precise laser forming of the tip results in a lower lesion entry profile, and the controlled laser welding of the balloon to the catheter improves the stent's trackability and flexibility.

"Continuous technology advancement is mandated by our customers and the very nature of interventional cardiology," said Al Novak, OrbusNeich's Chairman and CEO.  "We believe the underlying deliverability of a stent is, and will continue to be, a critically important factor that we strive to improve."

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first pro-healing stent, the Genous™ Stent, as well as other stents and balloons marketed under the names of Azule, R stent, Scoreflex™, Sapphire™, Sapphire II and Sapphire NC. Development stage products include the Combo™ Bio-engineered Sirolimus Eluting Stent, or Combo Stent, which combines the Genous pro-healing technology for rapid endothelial coverage with an abluminal sirolimus drug elution for the control of neointimal proliferation. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich, which has provided
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
2. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
5. Clinical Impact of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology
6. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
7. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
8. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
9. Data From Multiple Clinical Trials of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008
10. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
11. Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Levi & Korsinsky is investigating ... "the Company") (NasdaqGS: SIAL ) for possible ... law in connection with the sale of the Company ... to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 , ... to you. Under the terms of the ...
(Date:9/22/2014)... , Sept. 22, 2014 The western ... stage. It is largely a replacement market with ... The mergers, acquisitions and partnerships are redefining competitive ... This research service provides details about revenue forecasts, ... pricing trends across the country. The changing landscape ...
(Date:9/22/2014)... Sept. 22, 2014 Research and Markets ... for Neurotechnology: 2014-2018" report to their offering. ... the most comprehensive and up-to-date publication available covering the ... the technology, markets, competitors, and growth rates in four ... 2014 through 2018. It forecasts the number of systems ...
Breaking Medicine Technology:SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3The Market for Neurotechnology: 2014-2018 2
... SILVER SPRING, Md., Sept. 30 The U.S. ... companies that manufacture, distribute, and/or market unapproved single-ingredient ... daily prevention of gout, to treat acute gout ... Fever (FMF). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
... disease who used once-daily Neupro® (rotigotine) in the ... in addition to previously reported beneficial effects on ... this week at the 2nd World Parkinson Congress ... relevant improvements in PDQ-8 score. This is a ...
Cached Medicine Technology:FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine 2FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine 3Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 2Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 3Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 4Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 5Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 6Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 7
(Date:9/22/2014)... leather seat covers offered by Lseat.com are meticulously in ... to meet customers’ specific product needs and budget level. The ... leather seat covers . Furthermore, the firm has launched an ... the new range is now available at a discounted rate ... are produced, the company’s top designers also carefully pick out ...
(Date:9/22/2014)... Fashion Footwear Association of New York (FFANY) and leading ... research to the University of Pittsburgh Cancer Institute (UPCI), ... the proceeds of the 20th annual QVC Presents "FFANY ... several cancer research centers across the country, including UPCI ... has been selected to receive funds from this year,s ...
(Date:9/22/2014)... September 22, 2014 On Saturday, September 27, ... Playworks, a local nonprofit that is doing an amazing job ... including UHY employees, their families and friends will be spending ... paint on cement games and graphics, as well as clean ... was originally scheduled to occur in May but due to ...
(Date:9/22/2014)... and young adults at risk for sexually transmitted infections ... sexual behaviors, according to new recommendations from the U.S. ... million new sexually transmitted infections such as gonorrhea and ... people between 15 and 24 years old, according to ... Sept. 22 in Annals of Internal Medicine , ...
(Date:9/22/2014)... By Amy Norton ... -- Tiny preemies may fare better when newborn intensive care ... time with their infants, a new study finds. Researchers ... were more alert and were less distressed when their NICU ... families. The findings, published online Sept. 22 in the ...
Breaking Medicine News(10 mins):Health News:Great 2007-2012 Jeep Wrangler JK Real Leather Seat Covers Introduced by Lseat.com 2Health News:Heels for a cause: FFANY, QVC Present $240,000 from shoe sales to Pitt researchers 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3
... Results from the first,quantitative study measuring tobacco ... Comunidades Latinas Unidas En Servicio (CLUES), Blue,Cross and ... Minnesota(SM).,The report, titled "Tobacco Use in Minnesota: A ... adult Latinos overall are smoking at,a rate lower ...
... The holidays can become,stressful for many families -- the pressure ... friends, relatives and co-workers, and, this,year, the added weight of ... look to give the gift of companionship and joy by ... "Before giving a furry friend as ...
... confirmation of Sam Smith as the new Chief Executive Officer of ... Committee of the International Board of Directors on Tuesday. , ... ... announced today the unanimous confirmation of Sam Smith as the new ...
... of pre-screened,Greater China suppliers hope to end the ... Global Sources, (Nasdaq: GSOL ) December ... sanitaryware & plumbing; bathroom,& cleaning accessories; computer monitors, ... personal care products. , ...
... Commitment to GAC,s Work Advocating for Orphans and Highly ... , WASHINGTON, Dec. 4 Today, Global ... the Jolie-Pitt Foundation. The grant will support GAC,s ... Children (EPIWC) in the new Obama administration, ensure children ...
... Dec. 3 In recognition of the value the American ... to honor George Buchanan, M.D., and Timothy J. Ley, M.D., ... play in the training and professional development of hematologists early ... Each year, two awardees -- one from the discipline of ...
Cached Medicine News:Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 2Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 3Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 4Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 5Health News:A Season of Responsibility for New Pet Owners 2Health News:New CEO Takes Helm at Mercy Ships 2Health News:New CEO Takes Helm at Mercy Ships 3Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 2Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 3Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 4Health News:Jolie-Pitt Foundation Awards Second Grant to Global Action for Children 2Health News:Inspirational Hematologists Honored With Mentor Awards From the American Society of Hematology 2
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
Vertical punch designed to create a 1.5mm clean cylindrical hole. Rotatable for convenient positioning. Flat Handle. Overall length 87mm....
... neck. Piston assembly fits into neck ... to recoil back to ready position ... precision milled cavity in platform. Accepts ... 9.0mm. Designed for the preparation of ...
Medicine Products: